Emilio T. Rivera, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5290 Mcnutt Rd, Ste 109, Santa Teresa, NM 88008 Phone: 575-589-1144 Fax: 575-589-2008 |
News Archive
AcelRx Pharmaceuticals, Inc. announced today that results of its Phase 1 studies evaluating the pharmacokinetics of its oral transmucosal NanoTab(TM) formulation of sufentanil will be featured in two oral presentations at the upcoming American Society of Anesthesiologists Annual Meeting in New Orleans.
The Beryl Institute released a report highlighting results from its recent patient experience benchmarking study conducted in collaboration with Catalyst Healthcare Research, an independent marketing research firm.
Health Care REIT, Inc. (NYSE:HCN) today announced updated financial guidance for fiscal year 2009 as a result of its recent common stock public offering. On September 1, 2009, the company announced that it agreed to sell 8,000,000 shares of its common stock in an underwritten public offering.
The UC Cancer Institute is one of three centers internationally approved to test an experimental drug's safety and pharmacokinetics and also assess the clinical benefit against recurrent malignant glioma, an aggressive form of brain cancer.
› Verified 5 days ago